Global Attention to Monkeypox

PDF

Published: 2023-09-19

DOI: 10.56557/upjoz/2023/v44i203658

Page: 163-172


Yollugari Aruna Kumari *

Department of Pharmacology, Raghavendra Institute of Pharmaceutical Education and Research (RIPER)- Autonomous, Chiyyedu (Post), Anantapur, Andhra Pradesh-515721, India.

Kanala Somasekhar Reddy

Department of Pharmacology, Raghavendra Institute of Pharmaceutical Education and Research (RIPER)- Autonomous, Chiyyedu (Post), Anantapur, Andhra Pradesh-515721, India.

Vijay R. Chidrawar

SVKM’s NMIMS School of Pharmacy & Technology Management, Jadcharla, Telangana-509301, India.

Annadurai Gowtham

Department of Pharmacology, Raghavendra Institute of Pharmaceutical Education and Research (RIPER)- Autonomous, Chiyyedu (Post), Anantapur, Andhra Pradesh-515721, India.

Onamala Varalakshmi

Department of Pharmacology, Raghavendra Institute of Pharmaceutical Education and Research (RIPER)- Autonomous, Chiyyedu (Post), Anantapur, Andhra Pradesh-515721, India.

*Author to whom correspondence should be addressed.


Abstract

Monkeypox is brought on by a pox virus that is closely linked to the smallpox virus and is spread by intimate contact between humans and animals. When people come into contact with sick animals, they may unintentionally contract the monkeypox. Smallpox vaccinations cross-protect against MPXV due to antigenic similarities. Fever, headache, muscle aches, lymphadenopathy, and a recognisable rash that later develops into papules, vesicles, and pustules that scab over and recover are all signs of monkeypox (MPX). There are now two vaccines on the market: JYNNEOSTM (live, replication incompetent vaccinia virus) and ACAM2000® (live, replication competent vaccinia virus). Antivirals (such as tecovirimat, brincidofovir, and cidofovir) and vaccinia immune globulin intravenous (VIGIV) are available as therapies for monkeypox, albeit the majority of cases will have moderate and self-limited disease and supportive care is often sufficient. The ongoing outbreak, which has more than 10,000 cases in more than 50 nations between May and July 2022, illustrates how easily MPXV can spread among people and how this could pose a serious threat to public health with worldwide repercussions.

Keywords: Monkeypox, MPXV, zoonosis


How to Cite

Kumari , Y. A., Reddy , K. S., Chidrawar , V. R., Gowtham , A., & Varalakshmi, O. (2023). Global Attention to Monkeypox. UTTAR PRADESH JOURNAL OF ZOOLOGY, 44(20), 163–172. https://doi.org/10.56557/upjoz/2023/v44i203658

Downloads

Download data is not yet available.

References

(ICTV) ICoToV. Virus Taxonomy: 2020 Release. Available: https://talk.ictvonline.org/taxonomy.

Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, Steffen R. The changing epidemiology of human monkeypox—A potential threat? A systematic review. PLoS neglected tropical diseases. 2022 Feb 11;16(2): e0010141.

Strathdee SA, Smith DM, Halbrook M, Mbala-Kingebeni P, Abeles S, Torriani F, Rimoin A. The rapidly evolving monkeypox epidemic: A call to action to leave no one behind. PLoS Medicine. 2022 Oct 31;19(10):e1004128.

Centers for Disease Control and Prevention. Monkeypox. Available from: https://www.cdc.gov/ poxvirus/monkeypox/index.htm.

Durski KN, McCollum AM, Nakazawa Y, et al. Emergence of Monkeypox − West and Central Africa, 1970-2017. MMWR Morb Mortal Wkly Rep. 2018;67:306–10.

Gessain A, Nakoune E, Yazdanpanah Y. Monkeypox. New England Journal of Medicine. 2022 Nov 10;387(19):1783-93.

Thornhill JP, Barkati S, Walmsley S, Rockstroh J, Antinori A, Harrison LB, Palich R, Nori A, Reeves I, Habibi MS, Apea V. Monkeypox virus infection in humans across 16 countries—April–June 2022. New England Journal of Medicine. 2022 Aug 25;387(8):679-91.

Lum FM, Torres-Ruesta A, Tay MZ, Lin RT, Lye DC, Rénia L, Ng LF. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nature Reviews Immunology. 2022 Oct;22(10):597-613.

Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, Steffen R. The changing epidemiology of human monkeypox—A potential threat? A systematic review. PLoS neglected tropical diseases. 2022 Feb 11;16(2):e0010141.

Kumar N, Acharya A, Gendelman HE, Byrareddy SN. The 2022 outbreak and the pathobiology of the monkeypox virus. Journal of autoimmunity. 2022 Jun 25:102855.

Huang Y, Mu L, Wang W. Monkeypox: epidemiology, pathogenesis, treatment and prevention. Signal Transduction and Targeted Therapy. 2022 Nov 2;7(1):1-22.

Yinka-Ogunleye, A. et al. Outbreak of human monkeypox in Nigeria in 2017-18: a clinical and epidemiological report. Lancet Infect. Dis. 19, 872–879 (2019).

WHO.Multi-country monkeypox outbreak in non-endemic countries. https:// www.who.int/emergencies/disease-outbreak-news/item/2022-DON385 (2022).

Nuzzo, J. B., Borio, L. L. & Gostin, L. O. The WHO declaration of monkeypox as a global public health emergency. JAMA 328, 615–617 (2022).

CDC. 2022 Monkeypox outbreak global map. https://www.cdc.gov/poxvirus/ monkeypox/response/2022/world-map.html (2022).

CHP investigates imported monkeypox case and alert level of the preparedness and response plan for monkeypox activated. https://www.info.gov.hk/gia/ general/202209/06/P2022090600594.htm?fontSize=1 (2022).

NDTV. Monkeypox symptoms, prevention as india records 4 cases. 2022. Available at: https://www.ndtv.com/india-news/ monkeypox-outbreak-check-symptoms-prevention-as-india-records-4-cases-3190470. Accessed on 27 July 2022.

Lum FM, Torres-Ruesta A, Tay MZ, Lin RT, Lye DC, Rénia L, Ng LF. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nature Reviews Immunology. 2022 Oct;22(10):597-613.

Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution. Viruses. 2020 Nov 5;12(11):1257.

Lum FM, Torres-Ruesta A, Tay MZ, Lin RT, Lye DC, Rénia L, Ng LF. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nature Reviews Immunology. 2022 Oct;22(10):597-613.

Kumar N, Acharya A, Gendelman HE, Byrareddy SN. The 2022 outbreak and the pathobiology of the monkeypox virus. Journal of autoimmunity. 2022 Jun 25:102855.

Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution. Viruses. 2020 Nov 5;12(11):1257.

Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution. Viruses. 2020 Nov 5;12(11):1257.

Lum FM, Torres-Ruesta A, Tay MZ, Lin RT, Lye DC, Rénia L, Ng LF. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nature Reviews Immunology. 2022 Oct;22(10): 597-613.

Bunge EM, Hoet B, Chen L, et al. The changing epidemiology of human monkeypox-a potential threat a systematic review. PLoS Negl Trop Dis. 2022;16: e0010141.

Gessain A, Nakoune E, Yazdanpanah Y. Monkeypox. New England Journal of Medicine. 2022 Nov 10;387(19):1783-93.

Huang Y, Mu L, Wang W. Monkeypox: epidemiology, pathogenesis, treatment and prevention. Signal Transduction and Targeted Therapy. 2022 Nov 2;7(1):1-22.

Jenewari, F.O. Monkey Pox in Nigeria: Epidemiology and Prevention. In Proceedings of the Problems and Prospects for the Development of Modern Medicine, GomSMU, Kharkiv, Ukrainian, 2–3 May 2019; pp. 194–195.

Okoli, S.C.; Kikelomo Amao, L.; Akinrogbe, J.T.; Iniobong, J.-I.; Burga, J. Outbreak Investigation of Monkeypox in Akwa Ibom State: A Matched Case Control Study 14th-24th October 2019. East Afr. J. Health Sci. 2019, 4, 37–44.

Beer, E.M.; Bhargavi Rao, V. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS Negl. Trop. Dis. 2019, 13, 1–20. [CrossRef] [PubMed].

Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution. Viruses 2020; 1.

Tenthorey JL, Emerman M, Malik HS. Evolutionary landscapes of host-virus arms races. Annual Review of Immunology. 2022 Apr 26;40:271-94.

Lum FM, Torres-Ruesta A, Tay MZ, Lin RT, Lye DC, Rénia L, Ng LF. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nature Reviews Immunology. 2022 Oct;22(10):597-613.

Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution. Viruses. 2020 Nov 5;12(11):1257.

Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, Steffen R. The changing epidemiology of human monkeypox—A potential threat? A systematic review. PLoS neglected tropical diseases. 2022 Feb 11;16(2):e0010141.

[36] Lum FM, Torres-Ruesta A, Tay MZ, Lin RT, Lye DC, Rénia L, Ng LF. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nature Reviews Immunology. 2022 Oct;22(10): 597-613.

Haller SL, Peng C, McFadden G, Rothenburg S. Poxviruses and the evolution of host range and virulence. Infection, Genetics and Evolution. 2014 Jan 1;21:15-40.

Lum FM, Torres-Ruesta A, Tay MZ, Lin RT, Lye DC, Rénia L, Ng LF. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nature Reviews Immunology. 2022 Oct;22(10):597-613.

Gong Q, Wang C, Chuai X, Chiu S. Monkeypox virus: a re-emergent threat to humans. Virologica Sinica. 2022 Jul 9.

Moore M, Zahra F. Monkeypox. StatPearls [Internet]: StatPearls Publishing;2022;Availableat:https://www.ncbi.nlm.nih.gov/books/NBK574519/ [Last Access: 24 March 2022].

Gong Q, Wang C, Chuai X, Chiu S. Monkeypox virus: a re-emergent threat to humans. Virologica Sinica. 2022 Jul 9.

Lum FM, Torres-Ruesta A, Tay MZ, Lin RT, Lye DC, Rénia L, Ng LF. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nature Reviews Immunology. 2022 Oct;22(10):597-613.

Lum FM, Torres-Ruesta A, Tay MZ, Lin RT, Lye DC, Rénia L, Ng LF. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nature Reviews Immunology. 2022 Oct;22(10):597-613.

Beer EM, Rao VB. A systematic review of the epidemiology of human monkeypox outbreaks and implications for outbreak strategy. PLoS neglected tropical diseases. 2019 Oct 16;13(10):e0007791.

Lum FM, Torres-Ruesta A, Tay MZ, Lin RT, Lye DC, Rénia L, Ng LF. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nature Reviews Immunology. 2022 Oct;22(10):597-613.

Ministry of Health and Family Welfare, Govt. of India. Guidelines for management of monkeypox disease.

Available:https://main.mohfw.gov.in/sites/default/files/Guidelines%20for%20Management%20of%20Monkeypox%20Disease.pdf. Accessed on 24 July 2022.

Mitjà O, Ogoina D, Titanji BK, Galvan C, Muyembe JJ, Marks M, Orkin CM. Monkeypox. The Lancet. 2023 Jan 7;401(10370):60-74.

Brown, K.; Leggat, P.A. Human monkeypox: Current state of knowledge and implications for the future. Trop. Med. Infect. Dis. 2016, 1, 8. [CrossRef].

Nasir, I.A.; Dangana, A.; Ojeamiren, I.; Emeribe, A.U. Reminiscing the recent incidence of monkeypox in Nigeria: Its ecologic-epidemiology and literature review. Port Harcourt Med. J. 2018, 11, 1–9. [CrossRef].

Kozlov M. Monkeypox vaccination begins — can the global outbreaks be contained? Nature 2022; 606: 444-445.

Moore M, Zahra F. Monkeypox. StatPearls [Internet]: StatPearls Publishing;2022;Availableat:https://www.ncbi.nlm.nih.gov/books/NBK574519/ [Last Access: 24 March 2022].

Petersen, B.W.; Kabamba, J.; Mccollum, A.M.; Lushima, R.S.; Wemakoy, E.O.; Jacques, J.; Tamfum, M.; Nguete, B.; Reynolds, M.G. Vaccinating against monkeypox in the Democratic Republic of the Congo. Antivir. Res. 2018, 11, 1–23. [CrossRef] [PubMed].

Kumar N, Acharya A, Gendelman HE, Byrareddy SN. The 2022 outbreak and the pathobiology of the monkeypox virus. Journal of autoimmunity. 2022 Jun 25:102855.

Siegrist EA, Sassine J. Antivirals With Activity Against Mpox: A Clinically Oriented Review. Clinical Infectious Diseases. 2023 Jan 1;76(1):155-64.

Kmiec D, Kirchhoff F. Monkeypox: a new threat?. International journal of molecular sciences. 2022 Jul 17;23(14):7866.

Mileto D, Riva A, Cutrera M, Moschese D, Mancon A, Meroni L, Giacomelli A, Bestetti G, Rizzardini G, Gismondo MR, Antinori S. New challenges in human monkeypox outside Africa: A review and case report from Italy. Travel medicine and infectious disease. 2022 Jun 20:102386.

Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox virus in Nigeria: infection biology, epidemiology, and evolution. Viruses. 2020 Nov 5;12(11):1257.

Huang Y, Mu L, Wang W. Monkeypox: epidemiology, pathogenesis, treatment and prevention. Signal Transduction and Targeted Therapy. 2022 Nov 2;7(1):1-22.

Hutson CL, Kondas AV, Mauldin MR, Doty JB, Grossi IM, Morgan CN, Ostergaard SD, Hughes CM, Nakazawa Y, Kling C, Martin BE. Pharmacokinetics and efficacy of a potential smallpox therapeutic, brincidofovir, in a lethal monkeypox virus animal model. MSphere. 2021 Feb 24;6(1):e00927-20.

Grosenbach, D. W. et al. Oral tecovirimat for the treatment of smallpox. N. Engl. J. Med. 379, 44–53 (2018).

Lum FM, Torres-Ruesta A, Tay MZ, Lin RT, Lye DC, Rénia L, Ng LF. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nature Reviews Immunology. 2022 Oct;22(10):597-613.

Sherwat, A., Brooks, J. T., Birnkrant, D. & Kim, P. Tecovirimat and the treatment of monkeypox - past, present, and future considerations. N. Engl. J. Med. 387, 579–581 (2022).

Adler H. et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect. Dis. 22, 1153–1162 (2022).

Desai AN, et al. Compassionate use of tecovirimat for the treatment of monkeypox infection. JAMA. 2022;328:1348–1350.

CDC. Demographics of patients receiving TPOXX for treatment ofmonkeypox.

Available:https://www.cdc.gov/poxvirus/monkeypox/response/2022/demographicsTPOXX.html (2022).

Del Rio C, Malani PN. Update on the monkeypox outbreak. JAMA. 2022;328: 921–922.

Guarner J, Del Rio C, Malani PN. Monkeypox in 2022-what clinicians need to know. JAMA. 2022;328:139– 140.

Rabaan AA, Abas AH, Tallei TE, Al‐Zaher MA, Al‐Sheef NM, Fatimawali, Al‐Nass EZ, Al‐Ebrahim EA, Effendi Y, Idroes R, Alhabib MF. Monkeypox outbreak 2022: What we know so far and its potential drug targets and management strategies. Journal of Medical Virology. 2023;95(1): e28306.

Kozlov M. Monkeypox outbreaks: 4 key questions researchers have. Nature. 2022;606(7913):238–239. Available:https://doi.org/10.1038/d41586-022-01493-6.